FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies
South San Francisco, CA -- February 16, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair® (omalizumab) for the reduction of allergic...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Allergy | Allergy & Immunology | Children | Drugs & Pharmacology | Food Allergy | Food and Drug Administration (FDA) | Xolair